Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PASG
#4349
Passage Bio, Inc. - Common Stock
5.7
7
USD
+1.76%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.76%
Monthly Change
+8.46%
6 month change
-34.73%
Year Change
-34.73%
Previous Close
5.6
7
Open
5.7
7
Low
5.7
7
High
5.7
7
Volume
1
Markets
US Stock Market
Healthcare
PASG
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
2.69 M
2.71 M
2.73 M
2.78 M
3.11 M
3.21 M
3.21 M
Valuation ratios
Enterprise value
1.24 B
215.79 M
53.88 M
28.39 M
-2.33 M
-8.45 M
-16.75 M
Price to earnings ratio
—
-1.82
-0.65
-0.48
-0.53
-0.82
-0.44
Price to sales ratio
—
—
—
106.54
34.26
25.52
11.3
Price to cash flow ratio
—
2.67
0.75
0.63
0.71
-1.19
-0.54
Price to book ratio
—
1.06
0.44
0.44
0.56
2
0.16
Enterprise value to EBITDA ratio
—
—
—
-0.64
0.09
0.36
0.84
Profitability ratios
Return on assets %
-0.34
-0.52
-0.56
-0.68
-0.63
-0.73
-0.21
Return on equity %
-0.37
-0.58
-0.68
-0.92
-1.06
-2.43
-0.64
Return on invested capital %
-3 024.1
-3 450.49
-1 607.84
-1 114.38
-906.07
—
—
Gross margin %
—
—
—
100
100
100
100
Operating margin %
—
—
—
23.41 K
-7 132.73
-3 360.33
-2 316.57
EBITDA margin %
—
—
—
9 541.04
-2 649.75
-1 621.81
-1 208.43
Net margin %
—
—
—
22.04 K
-6 562.01
-3 103.07
-2 123.31
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.98
11.02
10.74
7.22
4.07
2.07
1.73
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
-0
0.01
0.02
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-47.57
-43.44
-28.59
-15.88
-9.93
-9.62
EBIT per share
—
—
—
-16.82
-9.68
-7.74
-6.49
EBITDA per share
—
—
—
-16.14
-8.66
-7.5
-6.28
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
118.39
69.67
41.76
25.41
14.59
10.4
Net current asset value per share
—
121.88
72.4
43.1
26.1
15.05
10.84
Tangible book value per share
—
119.47
73.99
40.66
20.28
5.91
3.67
Working capital per share
—
110.82
65.66
37.13
19.68
7.78
4.57
Book value per share
—
119.47
73.99
40.66
20.28
5.91
3.67
News
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.01%
Lucid Capital Markets initiates Passage Bio stock with Buy rating
Monday’s Insider Moves: Key Buys and Sells in US Stocks Revealed
Lynx1 Capital buys Passage Bio (PASG) shares worth $223,734
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
Guggenheim lowers Passage Bio stock price target to $10 from $40
Canaccord Genuity lowers Passage Bio stock price target to $67 from $260
Lynx1 capital buys Passage Bio (PASG) shares worth $733,825
Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested - TipRanks.com
Passage Bio announces 1-for-20 reverse stock split to regain compliance
Passage Bio reports updated data on PBFT02 for FTD treatment